LCTX vs SCHW · rev $2.8M vs P/E 19, rev $13.55B
Lineage Cell Therapeutics Inc (LCTX) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
LCTX currently screens at market cap $213.6M. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the LCTX and SCHW stock pages for the full models.
Not investment advice.